ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 156 filers reported holding ITEOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,860,662 | -15.4% | 1,813,759 | +2.3% | 0.00% | -100.0% |
| Q2 2023 | $23,479,181 | -2.7% | 1,773,352 | +0.0% | 0.00% | 0.0% |
| Q1 2023 | $24,130,380 | -32.1% | 1,772,989 | -2.5% | 0.00% | 0.0% |
| Q4 2022 | $35,525,655 | +6.5% | 1,819,030 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $33,358,000 | -0.6% | 1,751,100 | +7.5% | 0.00% | 0.0% |
| Q2 2022 | $33,569,000 | -29.3% | 1,629,586 | +10.4% | 0.00% | 0.0% |
| Q1 2022 | $47,499,000 | -3.8% | 1,476,042 | +39.1% | 0.00% | 0.0% |
| Q4 2021 | $49,392,000 | +195.5% | 1,060,810 | +71.4% | 0.00% | – |
| Q3 2021 | $16,714,000 | +26.5% | 619,031 | +20.2% | 0.00% | – |
| Q2 2021 | $13,209,000 | -44.3% | 514,975 | -25.8% | 0.00% | -100.0% |
| Q1 2021 | $23,711,000 | +7.6% | 693,751 | +6.4% | 0.00% | 0.0% |
| Q4 2020 | $22,043,000 | +109.6% | 651,778 | +52.9% | 0.00% | – |
| Q3 2020 | $10,517,000 | – | 426,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |